| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 165 | 2025 | 729 | 23.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 66 | 2025 | 687 | 10.410 |
Why?
|
| Glucose | 73 | 2025 | 467 | 9.260 |
Why?
|
| Exercise | 54 | 2025 | 936 | 7.730 |
Why?
|
| Insulin Resistance | 45 | 2025 | 408 | 7.390 |
Why?
|
| Physical Conditioning, Animal | 23 | 2025 | 43 | 6.840 |
Why?
|
| Insulin | 59 | 2025 | 687 | 5.620 |
Why?
|
| Obesity | 40 | 2025 | 1227 | 5.490 |
Why?
|
| Diet, High-Fat | 16 | 2025 | 174 | 5.470 |
Why?
|
| Energy Metabolism | 30 | 2025 | 378 | 5.270 |
Why?
|
| AMP-Activated Protein Kinases | 34 | 2020 | 85 | 5.030 |
Why?
|
| Diacylglycerol Kinase | 9 | 2024 | 11 | 4.120 |
Why?
|
| Circadian Rhythm | 18 | 2025 | 381 | 3.670 |
Why?
|
| Muscle Fibers, Skeletal | 28 | 2025 | 93 | 3.670 |
Why?
|
| Lipid Metabolism | 21 | 2024 | 220 | 3.550 |
Why?
|
| Signal Transduction | 62 | 2025 | 3016 | 3.370 |
Why?
|
| Circadian Clocks | 10 | 2023 | 47 | 2.990 |
Why?
|
| Adaptation, Physiological | 15 | 2025 | 128 | 2.910 |
Why?
|
| Animals | 130 | 2025 | 20530 | 2.730 |
Why?
|
| DNA Methylation | 15 | 2024 | 290 | 2.730 |
Why?
|
| Epigenesis, Genetic | 13 | 2024 | 380 | 2.640 |
Why?
|
| Mice | 93 | 2025 | 10768 | 2.580 |
Why?
|
| Adipose Tissue | 12 | 2024 | 295 | 2.490 |
Why?
|
| Mice, Inbred C57BL | 42 | 2025 | 3384 | 2.400 |
Why?
|
| Mitochondria | 15 | 2024 | 366 | 2.020 |
Why?
|
| Transcriptome | 10 | 2022 | 379 | 1.810 |
Why?
|
| Blood Glucose | 20 | 2025 | 484 | 1.790 |
Why?
|
| Male | 115 | 2025 | 29366 | 1.780 |
Why?
|
| Phosphorylation | 39 | 2025 | 935 | 1.780 |
Why?
|
| Humans | 165 | 2025 | 62455 | 1.780 |
Why?
|
| Multienzyme Complexes | 12 | 2008 | 80 | 1.740 |
Why?
|
| Muscle Contraction | 15 | 2024 | 202 | 1.710 |
Why?
|
| Adenylate Kinase | 6 | 2017 | 18 | 1.590 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 831 | 1.580 |
Why?
|
| Phosphoproteins | 9 | 2025 | 219 | 1.540 |
Why?
|
| Liver | 12 | 2025 | 838 | 1.510 |
Why?
|
| Diabetes Mellitus | 6 | 2019 | 535 | 1.500 |
Why?
|
| Metabolic Diseases | 6 | 2021 | 57 | 1.470 |
Why?
|
| Mice, Transgenic | 16 | 2024 | 1265 | 1.350 |
Why?
|
| Homeostasis | 13 | 2022 | 366 | 1.330 |
Why?
|
| Calcineurin | 5 | 2009 | 47 | 1.310 |
Why?
|
| RNA, Messenger | 19 | 2022 | 1520 | 1.270 |
Why?
|
| Glucose Tolerance Test | 11 | 2022 | 97 | 1.260 |
Why?
|
| GTPase-Activating Proteins | 13 | 2016 | 69 | 1.230 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 18 | 2024 | 33 | 1.210 |
Why?
|
| Proteomics | 8 | 2025 | 283 | 1.210 |
Why?
|
| Mice, Knockout | 24 | 2025 | 2093 | 1.170 |
Why?
|
| Glucose Intolerance | 7 | 2024 | 90 | 1.150 |
Why?
|
| Gene Expression | 17 | 2020 | 834 | 1.140 |
Why?
|
| Physical Endurance | 11 | 2021 | 48 | 1.110 |
Why?
|
| Insulin Receptor Substrate Proteins | 8 | 2021 | 55 | 1.110 |
Why?
|
| Glycogen | 16 | 2017 | 42 | 1.100 |
Why?
|
| Inflammation | 7 | 2025 | 1136 | 1.090 |
Why?
|
| Gene Expression Profiling | 11 | 2020 | 761 | 1.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 16 | 2018 | 202 | 1.070 |
Why?
|
| Fatty Acids | 10 | 2024 | 200 | 1.060 |
Why?
|
| Aminoimidazole Carboxamide | 14 | 2017 | 16 | 1.060 |
Why?
|
| Hypoglycemic Agents | 9 | 2016 | 214 | 1.030 |
Why?
|
| Ribonucleotides | 14 | 2017 | 19 | 1.010 |
Why?
|
| Metabolomics | 3 | 2025 | 54 | 1.010 |
Why?
|
| Exercise Therapy | 4 | 2022 | 104 | 1.010 |
Why?
|
| Leptin | 4 | 2018 | 85 | 1.010 |
Why?
|
| Muscles | 3 | 2023 | 179 | 1.000 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 34 | 0.990 |
Why?
|
| Proteome | 8 | 2025 | 150 | 0.980 |
Why?
|
| Protein Kinases | 11 | 2015 | 152 | 0.980 |
Why?
|
| Rats | 23 | 2024 | 1976 | 0.970 |
Why?
|
| Weight Loss | 4 | 2019 | 272 | 0.970 |
Why?
|
| Diet | 7 | 2021 | 522 | 0.900 |
Why?
|
| Heat-Shock Proteins | 5 | 2013 | 64 | 0.900 |
Why?
|
| Cells, Cultured | 26 | 2025 | 2148 | 0.880 |
Why?
|
| Mitochondrial Proteins | 10 | 2021 | 103 | 0.870 |
Why?
|
| Diglycerides | 5 | 2017 | 24 | 0.860 |
Why?
|
| Transcription Factors | 18 | 2024 | 1500 | 0.860 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2021 | 712 | 0.850 |
Why?
|
| Cardiovascular System | 1 | 2024 | 40 | 0.830 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2018 | 120 | 0.830 |
Why?
|
| Precision Medicine | 3 | 2025 | 118 | 0.830 |
Why?
|
| Urocortins | 2 | 2021 | 5 | 0.820 |
Why?
|
| Gene Expression Regulation | 17 | 2018 | 1601 | 0.780 |
Why?
|
| Histones | 4 | 2022 | 480 | 0.770 |
Why?
|
| Protein Kinase C | 6 | 2017 | 103 | 0.750 |
Why?
|
| Resistance Training | 4 | 2025 | 21 | 0.730 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2008 | 216 | 0.720 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 452 | 0.710 |
Why?
|
| Enzyme Inhibitors | 7 | 2019 | 372 | 0.700 |
Why?
|
| MicroRNAs | 8 | 2025 | 644 | 0.690 |
Why?
|
| Female | 52 | 2025 | 32375 | 0.690 |
Why?
|
| DNA-Binding Proteins | 12 | 2025 | 1176 | 0.680 |
Why?
|
| Gene Silencing | 5 | 2012 | 389 | 0.660 |
Why?
|
| Case-Control Studies | 11 | 2021 | 1107 | 0.660 |
Why?
|
| Glycolysis | 9 | 2025 | 58 | 0.650 |
Why?
|
| Epigenomics | 1 | 2020 | 61 | 0.640 |
Why?
|
| Muscle Proteins | 6 | 2018 | 118 | 0.640 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2018 | 18 | 0.630 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2019 | 2 | 0.630 |
Why?
|
| Paternal Inheritance | 1 | 2019 | 7 | 0.620 |
Why?
|
| Pandemics | 2 | 2021 | 661 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 8 | 2024 | 669 | 0.620 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 9 | 0.620 |
Why?
|
| Glucose Transporter Type 4 | 11 | 2018 | 60 | 0.620 |
Why?
|
| Motor Activity | 4 | 2019 | 343 | 0.610 |
Why?
|
| Amino Acids, Branched-Chain | 4 | 2025 | 13 | 0.610 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2019 | 612 | 0.600 |
Why?
|
| Chemokines | 1 | 2018 | 95 | 0.590 |
Why?
|
| Oxidation-Reduction | 9 | 2024 | 325 | 0.590 |
Why?
|
| Middle Aged | 42 | 2025 | 17293 | 0.580 |
Why?
|
| Ceramides | 3 | 2025 | 25 | 0.580 |
Why?
|
| Interleukin-6 | 7 | 2014 | 319 | 0.570 |
Why?
|
| Biopsy | 9 | 2021 | 429 | 0.570 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 16 | 0.570 |
Why?
|
| Down-Regulation | 4 | 2025 | 317 | 0.560 |
Why?
|
| Aging | 4 | 2025 | 738 | 0.560 |
Why?
|
| Carboxylesterase | 1 | 2017 | 4 | 0.540 |
Why?
|
| Biomarkers | 8 | 2025 | 1379 | 0.540 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2016 | 2 | 0.540 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 49 | 0.540 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 14 | 0.540 |
Why?
|
| Nuclear Proteins | 6 | 2013 | 770 | 0.540 |
Why?
|
| Life Style | 2 | 2016 | 311 | 0.530 |
Why?
|
| Adipose Tissue, Brown | 3 | 2024 | 117 | 0.530 |
Why?
|
| Body Composition | 4 | 2025 | 152 | 0.530 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 56 | 0.520 |
Why?
|
| Congresses as Topic | 1 | 2016 | 74 | 0.520 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2022 | 262 | 0.520 |
Why?
|
| Adipocytes | 8 | 2024 | 268 | 0.510 |
Why?
|
| Biological Transport | 13 | 2017 | 295 | 0.510 |
Why?
|
| Science | 1 | 2016 | 34 | 0.510 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 172 | 0.510 |
Why?
|
| In Vitro Techniques | 9 | 2017 | 486 | 0.500 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2015 | 198 | 0.500 |
Why?
|
| Triglycerides | 9 | 2019 | 244 | 0.490 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 422 | 0.490 |
Why?
|
| Cell Differentiation | 6 | 2018 | 1339 | 0.490 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 85 | 0.480 |
Why?
|
| Health | 1 | 2015 | 31 | 0.480 |
Why?
|
| Phosphotransferases | 2 | 2005 | 23 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2024 | 620 | 0.470 |
Why?
|
| Hyperglycemia | 3 | 2008 | 104 | 0.460 |
Why?
|
| Adult | 38 | 2025 | 16564 | 0.460 |
Why?
|
| Phosphatidylinositol 3-Kinases | 11 | 2007 | 171 | 0.460 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 47 | 0.460 |
Why?
|
| Muscle Cells | 6 | 2019 | 28 | 0.450 |
Why?
|
| Mice, Obese | 6 | 2022 | 80 | 0.450 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 70 | 0.450 |
Why?
|
| RNA, Small Interfering | 8 | 2021 | 893 | 0.450 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 124 | 0.440 |
Why?
|
| Fatty Acids, Nonesterified | 5 | 2019 | 56 | 0.440 |
Why?
|
| Research | 1 | 2015 | 192 | 0.430 |
Why?
|
| NAD | 2 | 2025 | 53 | 0.430 |
Why?
|
| Lipids | 8 | 2022 | 316 | 0.420 |
Why?
|
| Receptors, Steroid | 2 | 2025 | 26 | 0.410 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2025 | 27 | 0.410 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2009 | 11 | 0.400 |
Why?
|
| Fasting | 4 | 2021 | 51 | 0.400 |
Why?
|
| Computational Biology | 4 | 2020 | 352 | 0.390 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 3 | 2025 | 5 | 0.380 |
Why?
|
| Trans-Activators | 6 | 2012 | 309 | 0.360 |
Why?
|
| Cell Line | 9 | 2024 | 2033 | 0.360 |
Why?
|
| Gastric Bypass | 3 | 2019 | 76 | 0.360 |
Why?
|
| Tissue Extracts | 1 | 2010 | 11 | 0.340 |
Why?
|
| Mitochondria, Muscle | 6 | 2024 | 16 | 0.340 |
Why?
|
| Carboxy-Lyases | 2 | 2018 | 7 | 0.330 |
Why?
|
| Blotting, Western | 9 | 2019 | 609 | 0.330 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2009 | 9 | 0.330 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 28 | 0.320 |
Why?
|
| Physical Exertion | 3 | 2013 | 78 | 0.320 |
Why?
|
| Mutation, Missense | 3 | 2015 | 184 | 0.320 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 157 | 0.320 |
Why?
|
| CpG Islands | 5 | 2018 | 216 | 0.320 |
Why?
|
| Twist-Related Protein 1 | 1 | 2009 | 11 | 0.320 |
Why?
|
| Sleep | 3 | 2018 | 225 | 0.310 |
Why?
|
| Cross-Over Studies | 7 | 2025 | 161 | 0.310 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2010 | 93 | 0.310 |
Why?
|
| Palmitic Acid | 3 | 2019 | 14 | 0.300 |
Why?
|
| Quadriceps Muscle | 2 | 2018 | 14 | 0.290 |
Why?
|
| Oxygen Consumption | 9 | 2024 | 208 | 0.290 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 82 | 0.290 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 87 | 0.290 |
Why?
|
| Lipid Peroxidation | 3 | 2019 | 65 | 0.290 |
Why?
|
| Receptor, Insulin | 4 | 2010 | 50 | 0.280 |
Why?
|
| Oxidative Phosphorylation | 4 | 2024 | 41 | 0.270 |
Why?
|
| Lipolysis | 2 | 2024 | 47 | 0.270 |
Why?
|
| Palmitates | 2 | 2022 | 21 | 0.270 |
Why?
|
| Enzyme Activation | 8 | 2014 | 379 | 0.270 |
Why?
|
| Protein Subunits | 6 | 2014 | 167 | 0.260 |
Why?
|
| Caloric Restriction | 2 | 2018 | 18 | 0.260 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2018 | 15 | 0.260 |
Why?
|
| Organ Specificity | 2 | 2020 | 192 | 0.260 |
Why?
|
| Contractile Proteins | 1 | 2006 | 14 | 0.260 |
Why?
|
| Adenosine Monophosphate | 2 | 2005 | 28 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2005 | 324 | 0.260 |
Why?
|
| Pancreas Transplantation | 1 | 2006 | 20 | 0.250 |
Why?
|
| Overweight | 4 | 2020 | 249 | 0.250 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 223 | 0.250 |
Why?
|
| Creatine | 2 | 2024 | 24 | 0.250 |
Why?
|
| Period Circadian Proteins | 4 | 2020 | 73 | 0.250 |
Why?
|
| Thinness | 3 | 2018 | 44 | 0.250 |
Why?
|
| Calcium | 3 | 2020 | 571 | 0.250 |
Why?
|
| Genome-Wide Association Study | 4 | 2022 | 360 | 0.250 |
Why?
|
| 3T3-L1 Cells | 3 | 2023 | 90 | 0.250 |
Why?
|
| Kynurenine | 2 | 2016 | 7 | 0.250 |
Why?
|
| High-Intensity Interval Training | 1 | 2025 | 2 | 0.240 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 111 | 0.240 |
Why?
|
| Isometric Contraction | 1 | 2005 | 45 | 0.240 |
Why?
|
| Thermogenesis | 2 | 2024 | 120 | 0.240 |
Why?
|
| Extracellular Fluid | 1 | 2025 | 11 | 0.240 |
Why?
|
| Deoxyglucose | 4 | 2012 | 32 | 0.230 |
Why?
|
| Creatine Kinase, Mitochondrial Form | 1 | 2024 | 1 | 0.230 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 50 | 0.230 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 70 | 0.230 |
Why?
|
| Transcription, Genetic | 3 | 2024 | 869 | 0.230 |
Why?
|
| Cytokines | 3 | 2025 | 933 | 0.230 |
Why?
|
| Hypoxia | 2 | 2022 | 113 | 0.230 |
Why?
|
| Glutaminase | 1 | 2024 | 2 | 0.230 |
Why?
|
| Hypertrophy | 2 | 2016 | 30 | 0.230 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 66 | 0.220 |
Why?
|
| Metformin | 1 | 2005 | 73 | 0.220 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 304 | 0.220 |
Why?
|
| Primary Cell Culture | 3 | 2019 | 78 | 0.220 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 146 | 0.220 |
Why?
|
| beta-Alanine | 1 | 2003 | 8 | 0.210 |
Why?
|
| Rats, Wistar | 7 | 2017 | 185 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2015 | 149 | 0.210 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 10 | 0.210 |
Why?
|
| CLOCK Proteins | 3 | 2019 | 47 | 0.210 |
Why?
|
| Alternative Splicing | 1 | 2024 | 127 | 0.210 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2017 | 206 | 0.210 |
Why?
|
| Cryptochromes | 3 | 2019 | 42 | 0.210 |
Why?
|
| Healthy Volunteers | 2 | 2021 | 76 | 0.210 |
Why?
|
| Ribosomes | 1 | 2025 | 162 | 0.210 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 169 | 0.200 |
Why?
|
| Organ Size | 2 | 2016 | 171 | 0.200 |
Why?
|
| Hindlimb | 1 | 2023 | 44 | 0.200 |
Why?
|
| Bicycling | 1 | 2003 | 21 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 337 | 0.200 |
Why?
|
| Chemokine CXCL12 | 1 | 2022 | 17 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 152 | 0.200 |
Why?
|
| Histone Code | 1 | 2022 | 27 | 0.200 |
Why?
|
| Adiposity | 3 | 2019 | 83 | 0.200 |
Why?
|
| Boronic Acids | 2 | 2014 | 28 | 0.200 |
Why?
|
| Isoenzymes | 5 | 2009 | 140 | 0.200 |
Why?
|
| Pyrazines | 2 | 2014 | 34 | 0.200 |
Why?
|
| ARNTL Transcription Factors | 2 | 2019 | 26 | 0.200 |
Why?
|
| Gene Ontology | 2 | 2020 | 38 | 0.190 |
Why?
|
| Mutation | 4 | 2018 | 2576 | 0.190 |
Why?
|
| Lactic Acid | 1 | 2022 | 75 | 0.190 |
Why?
|
| Ribonuclease III | 2 | 2020 | 84 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 131 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2017 | 22 | 0.190 |
Why?
|
| PPAR delta | 3 | 2006 | 10 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 219 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2020 | 86 | 0.190 |
Why?
|
| Adipocytes, White | 1 | 2022 | 27 | 0.190 |
Why?
|
| Neuronal Outgrowth | 1 | 2021 | 10 | 0.190 |
Why?
|
| Thymosin | 1 | 2021 | 8 | 0.190 |
Why?
|
| Pyrones | 3 | 2012 | 7 | 0.180 |
Why?
|
| Glucagon | 2 | 2014 | 33 | 0.180 |
Why?
|
| NF-kappa B | 3 | 2019 | 469 | 0.180 |
Why?
|
| Thermotolerance | 1 | 2021 | 2 | 0.180 |
Why?
|
| Environment | 2 | 2012 | 121 | 0.180 |
Why?
|
| Acetyl-CoA Carboxylase | 3 | 2014 | 17 | 0.180 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2012 | 19 | 0.180 |
Why?
|
| Thiophenes | 3 | 2012 | 29 | 0.180 |
Why?
|
| Autocrine Communication | 2 | 2013 | 31 | 0.180 |
Why?
|
| Young Adult | 10 | 2021 | 4607 | 0.180 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 365 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2022 | 183 | 0.180 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 130 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 83 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 128 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 19 | 0.170 |
Why?
|
| Osteoblasts | 1 | 2021 | 198 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2021 | 974 | 0.170 |
Why?
|
| Protein Biosynthesis | 2 | 2025 | 313 | 0.170 |
Why?
|
| Membrane Proteins | 3 | 2017 | 889 | 0.160 |
Why?
|
| Nutritional Status | 1 | 2020 | 98 | 0.160 |
Why?
|
| Osteonectin | 1 | 2019 | 2 | 0.160 |
Why?
|
| Eating | 1 | 2020 | 137 | 0.160 |
Why?
|
| Amino Acids | 1 | 2020 | 146 | 0.160 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2017 | 11 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2022 | 358 | 0.160 |
Why?
|
| Amino Acid Substitution | 3 | 2015 | 239 | 0.160 |
Why?
|
| Electroporation | 1 | 2019 | 34 | 0.160 |
Why?
|
| Time Factors | 9 | 2018 | 3737 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2019 | 614 | 0.160 |
Why?
|
| Models, Biological | 6 | 2020 | 1177 | 0.150 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 28 | 0.150 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 1592 | 0.150 |
Why?
|
| Glucose Clamp Technique | 5 | 2007 | 58 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 78 | 0.150 |
Why?
|
| Mental Health | 1 | 2022 | 361 | 0.150 |
Why?
|
| Metabolism | 1 | 2018 | 13 | 0.150 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2015 | 13 | 0.150 |
Why?
|
| Health Behavior | 1 | 2022 | 466 | 0.150 |
Why?
|
| Epoxy Compounds | 1 | 2018 | 10 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 24 | 0.150 |
Why?
|
| Immunoblotting | 3 | 2008 | 202 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 287 | 0.150 |
Why?
|
| Exosomes | 1 | 2018 | 47 | 0.150 |
Why?
|
| Running | 1 | 2019 | 83 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2018 | 345 | 0.150 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2018 | 22 | 0.150 |
Why?
|
| Kinetics | 6 | 2013 | 763 | 0.140 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 48 | 0.140 |
Why?
|
| Protein Isoforms | 4 | 2024 | 199 | 0.140 |
Why?
|
| DNA | 1 | 2022 | 840 | 0.140 |
Why?
|
| PPAR gamma | 2 | 2009 | 76 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 572 | 0.140 |
Why?
|
| Lampreys | 1 | 2017 | 5 | 0.140 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 3 | 0.140 |
Why?
|
| Ion Transport | 1 | 2017 | 21 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2016 | 11 | 0.140 |
Why?
|
| Bortezomib | 2 | 2014 | 56 | 0.130 |
Why?
|
| Prevalence | 1 | 2021 | 1343 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 95 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 201 | 0.130 |
Why?
|
| Social Networking | 1 | 2016 | 23 | 0.130 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 44 | 0.130 |
Why?
|
| Risk Factors | 4 | 2021 | 5287 | 0.130 |
Why?
|
| Role | 1 | 2016 | 14 | 0.130 |
Why?
|
| Adiponectin | 2 | 2008 | 35 | 0.130 |
Why?
|
| Career Mobility | 1 | 2016 | 64 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 2 | 2012 | 8 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2012 | 14 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2016 | 181 | 0.120 |
Why?
|
| Heterozygote | 1 | 2016 | 168 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 2165 | 0.120 |
Why?
|
| Athletes | 1 | 2017 | 108 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 14 | 0.120 |
Why?
|
| Fatty Acid Transport Proteins | 2 | 2018 | 7 | 0.120 |
Why?
|
| PPAR alpha | 3 | 2016 | 34 | 0.120 |
Why?
|
| Walking | 2 | 2015 | 237 | 0.120 |
Why?
|
| Nuclear Respiratory Factor 1 | 3 | 2013 | 5 | 0.120 |
Why?
|
| Biphenyl Compounds | 3 | 2012 | 32 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2017 | 215 | 0.120 |
Why?
|
| Dietary Carbohydrates | 1 | 2015 | 60 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 43 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 56 | 0.120 |
Why?
|
| Transfection | 4 | 2015 | 688 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 46 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2015 | 61 | 0.120 |
Why?
|
| Electric Stimulation | 2 | 2005 | 140 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 220 | 0.120 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 2003 | 43 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
| Protein Carbonylation | 1 | 2014 | 1 | 0.120 |
Why?
|
| Algorithms | 1 | 2020 | 1003 | 0.110 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 30 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2014 | 16 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2015 | 168 | 0.110 |
Why?
|
| Manometry | 1 | 2014 | 27 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2025 | 7 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 406 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2015 | 229 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2014 | 293 | 0.110 |
Why?
|
| Biological Assay | 1 | 2014 | 58 | 0.110 |
Why?
|
| Methotrexate | 1 | 2014 | 80 | 0.110 |
Why?
|
| Angiography | 1 | 2014 | 151 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 45 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2013 | 37 | 0.110 |
Why?
|
| RNA Interference | 2 | 2014 | 611 | 0.110 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 14 | 0.110 |
Why?
|
| Cell Hypoxia | 2 | 2012 | 42 | 0.110 |
Why?
|
| Muscle Development | 1 | 2013 | 54 | 0.100 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 49 | 0.100 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2012 | 7 | 0.100 |
Why?
|
| Glutamine | 2 | 2024 | 46 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2010 | 33 | 0.100 |
Why?
|
| Fetal Development | 1 | 2012 | 17 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 17 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2012 | 14 | 0.100 |
Why?
|
| Spermine | 1 | 2012 | 3 | 0.100 |
Why?
|
| High Mobility Group Proteins | 2 | 2012 | 24 | 0.100 |
Why?
|
| Base Sequence | 3 | 2010 | 1329 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 97 | 0.100 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 15 | 0.100 |
Why?
|
| Body Mass Index | 5 | 2011 | 861 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2014 | 370 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2011 | 392 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 887 | 0.090 |
Why?
|
| Body Weight | 2 | 2009 | 377 | 0.090 |
Why?
|
| Genome, Human | 1 | 2013 | 233 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 185 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2017 | 844 | 0.090 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 12 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 62 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2014 | 469 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2009 | 12 | 0.080 |
Why?
|
| Phenotype | 3 | 2018 | 1191 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 148 | 0.080 |
Why?
|
| Acyltransferases | 1 | 2009 | 31 | 0.080 |
Why?
|
| Ion Channels | 2 | 2008 | 90 | 0.080 |
Why?
|
| Electron Transport | 1 | 2009 | 36 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2018 | 372 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 102 | 0.080 |
Why?
|
| Benzylamines | 1 | 2009 | 30 | 0.080 |
Why?
|
| Calorimetry, Indirect | 3 | 2019 | 31 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 129 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 34 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 216 | 0.080 |
Why?
|
| Ionophores | 1 | 2008 | 11 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 72 | 0.080 |
Why?
|
| Ionomycin | 1 | 2008 | 16 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 69 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2009 | 126 | 0.080 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 2009 | 3 | 0.080 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 86 | 0.080 |
Why?
|
| Monocytes | 1 | 2010 | 351 | 0.070 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2006 | 5 | 0.070 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 25 | 0.070 |
Why?
|
| C-Peptide | 2 | 2005 | 23 | 0.070 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2008 | 26 | 0.070 |
Why?
|
| Coenzyme A | 1 | 2008 | 6 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 50 | 0.070 |
Why?
|
| Acetyl Coenzyme A | 1 | 2008 | 24 | 0.070 |
Why?
|
| Oxygen | 2 | 2006 | 316 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2005 | 21 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2008 | 98 | 0.070 |
Why?
|
| Depression | 1 | 2014 | 883 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2009 | 152 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 170 | 0.070 |
Why?
|
| Protein Transport | 3 | 2018 | 405 | 0.070 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 410 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2013 | 706 | 0.070 |
Why?
|
| Protein Kinase C-delta | 2 | 2004 | 7 | 0.070 |
Why?
|
| Adipokines | 2 | 2022 | 30 | 0.070 |
Why?
|
| Tyrosine | 2 | 2006 | 93 | 0.070 |
Why?
|
| Aged | 6 | 2025 | 14203 | 0.070 |
Why?
|
| Neuregulins | 1 | 2006 | 9 | 0.070 |
Why?
|
| Filamins | 1 | 2006 | 8 | 0.070 |
Why?
|
| Dietary Fats | 2 | 2006 | 176 | 0.060 |
Why?
|
| Rats, Zucker | 2 | 2003 | 7 | 0.060 |
Why?
|
| Receptors, Adrenergic | 1 | 2006 | 8 | 0.060 |
Why?
|
| Swimming | 1 | 2005 | 27 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 90 | 0.060 |
Why?
|
| Transaminases | 2 | 2016 | 14 | 0.060 |
Why?
|
| Myoblasts | 1 | 2006 | 64 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 37 | 0.060 |
Why?
|
| Pregnancy | 1 | 2012 | 2307 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 91 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2025 | 21 | 0.060 |
Why?
|
| Pulse Wave Analysis | 2 | 2015 | 14 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2005 | 112 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2005 | 69 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 60 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 348 | 0.060 |
Why?
|
| United Kingdom | 1 | 2005 | 79 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 641 | 0.060 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 44 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 44 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 101 | 0.060 |
Why?
|
| Drug Industry | 1 | 2005 | 39 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2005 | 48 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2004 | 26 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2025 | 60 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 158 | 0.060 |
Why?
|
| Blood | 1 | 2004 | 30 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 166 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2004 | 8 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 28 | 0.050 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2003 | 4 | 0.050 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 10 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 376 | 0.050 |
Why?
|
| Protein Kinase C beta | 1 | 2003 | 6 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 16 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2003 | 21 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2003 | 24 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 140 | 0.050 |
Why?
|
| Protein Kinase C-theta | 1 | 2003 | 16 | 0.050 |
Why?
|
| Sports | 1 | 2004 | 96 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 292 | 0.050 |
Why?
|
| Arginine | 2 | 2015 | 122 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 279 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2003 | 28 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 313 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2024 | 107 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 36 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 542 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 111 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1443 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 26 | 0.050 |
Why?
|
| Metabolome | 1 | 2022 | 29 | 0.050 |
Why?
|
| Phosphocreatine | 1 | 2022 | 25 | 0.050 |
Why?
|
| Incretins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2015 | 513 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Nutrition Therapy | 1 | 2021 | 9 | 0.050 |
Why?
|
| Muscular Diseases | 1 | 2021 | 49 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2003 | 327 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2021 | 57 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 57 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2015 | 192 | 0.040 |
Why?
|
| Reference Values | 3 | 2007 | 335 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1138 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 302 | 0.040 |
Why?
|
| Exercise Test | 3 | 2010 | 249 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2021 | 106 | 0.040 |
Why?
|
| Chemokine CCL2 | 2 | 2010 | 56 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1634 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 747 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 339 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 334 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2018 | 10 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 148 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 483 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 35 | 0.040 |
Why?
|
| Tanzania | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 73 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 103 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 150 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 514 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 747 | 0.040 |
Why?
|
| Uncoupling Protein 3 | 2 | 2008 | 3 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 168 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 174 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 14 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 133 | 0.030 |
Why?
|
| Glycogen Synthase | 1 | 2016 | 4 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 56 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 494 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 444 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2017 | 119 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 297 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5554 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 428 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2015 | 19 | 0.030 |
Why?
|
| Software | 1 | 2019 | 381 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2529 | 0.030 |
Why?
|
| Histidine | 1 | 2015 | 34 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 898 | 0.030 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2015 | 1 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2015 | 45 | 0.030 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 12 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 126 | 0.030 |
Why?
|
| Kynurenic Acid | 1 | 2014 | 3 | 0.030 |
Why?
|
| Physical Conditioning, Human | 1 | 2014 | 2 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2014 | 1 | 0.030 |
Why?
|
| Greenland | 1 | 2014 | 1 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 2014 | 8 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 31 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 92 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 48 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 117 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 119 | 0.030 |
Why?
|
| Cytosol | 2 | 2006 | 180 | 0.030 |
Why?
|
| Piperidines | 1 | 2014 | 63 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 85 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 2 | 2005 | 59 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 58 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 51 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1988 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2015 | 195 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 202 | 0.030 |
Why?
|
| Karyopherins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 8 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 86 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 242 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 65 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 166 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 15 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 29 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2014 | 212 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 261 | 0.020 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2012 | 4 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 649 | 0.020 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 13 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 125 | 0.020 |
Why?
|
| Sulfites | 1 | 2011 | 5 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2011 | 18 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 40 | 0.020 |
Why?
|
| Cytosine | 1 | 2011 | 31 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 1716 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 187 | 0.020 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 1 | 2011 | 2 | 0.020 |
Why?
|
| Observation | 1 | 2010 | 30 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 122 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 51 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 265 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2010 | 3 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 60 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2010 | 20 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 520 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2439 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 57 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 46 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 187 | 0.020 |
Why?
|
| Ouabain | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 167 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 292 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 173 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 28 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 3246 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2009 | 78 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 205 | 0.020 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 1 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 27 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2009 | 135 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Hexokinase | 1 | 2008 | 11 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 109 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2008 | 29 | 0.020 |
Why?
|
| Receptors, Kainic Acid | 1 | 2008 | 2 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 14 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 74 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 149 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 16 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 116 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2009 | 68 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2008 | 42 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 49 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2008 | 33 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 176 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 125 | 0.020 |
Why?
|
| Exons | 1 | 2008 | 197 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 860 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 147 | 0.020 |
Why?
|
| Qb-SNARE Proteins | 1 | 2007 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 26 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 49 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 27 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 667 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 266 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 567 | 0.020 |
Why?
|
| Receptor, ErbB-4 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Body Size | 1 | 2006 | 24 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 189 | 0.020 |
Why?
|
| Caffeine | 1 | 2006 | 48 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2006 | 19 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2005 | 2 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 22 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 394 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 160 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 102 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2005 | 6 | 0.020 |
Why?
|
| Deuterium | 1 | 2005 | 24 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 71 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2006 | 113 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 202 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 47 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1065 | 0.010 |
Why?
|
| Imidazoles | 1 | 2005 | 80 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 74 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2005 | 82 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 198 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 111 | 0.010 |
Why?
|
| MADS Domain Proteins | 1 | 2004 | 2 | 0.010 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 142 | 0.010 |
Why?
|
| MEF2 Transcription Factors | 1 | 2004 | 10 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 15 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2004 | 12 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 174 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 166 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2004 | 16 | 0.010 |
Why?
|
| Family | 1 | 2006 | 240 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2004 | 12 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 57 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 37 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 698 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 368 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 258 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 2003 | 16 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 309 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 365 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 141 | 0.010 |
Why?
|
| Lipodystrophy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2530 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 420 | 0.010 |
Why?
|